Cargando…

Fingolimod for Irradiation-Induced Neurodegeneration

BACKGROUND: Cranial irradiation is a common therapy for the treatment of brain tumors, but unfortunately patients suffer from side effects, particularly cognitive impairment, caused by neurodegenerative and neuroinflammatory mechanisms. Finding a therapeutic agent protecting hippocampal neurons woul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Metzdorf, Judith, Hobloss, Zaynab, Schlevogt, Sibylle, Ayzenberg, Ilya, Stahlke, Sarah, Pedreiturria, Xiomara, Haupeltshofer, Steffen, Gold, Ralf, Tönges, Lars, Kleiter, Ingo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6633210/ https://www.ncbi.nlm.nih.gov/pubmed/31354410 http://dx.doi.org/10.3389/fnins.2019.00699

Ejemplares similares

Analysis of Neurogenesis during Experimental Autoimmune Encephalomyelitis Reveals Pitfalls of Bioluminescence Imaging
por: Ayzenberg, Ilya, et al.
Publicado: (2015)

Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations
por: Ayzenberg, Ilya, et al.
Publicado: (2016)

Fingolimod attenuates experimental autoimmune neuritis and contributes to Schwann cell-mediated axonal protection
por: Ambrosius, Björn, et al.
Publicado: (2017)

Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model
por: Wilmes, Anna T., et al.
Publicado: (2018)

Induction of Regulatory Properties in the Intestinal Immune System by Dimethyl Fumarate in Lewis Rat Experimental Autoimmune Neuritis
por: Pitarokoili, Kalliopi, et al.
Publicado: (2019)

Propionic Acid and Fasudil as Treatment against Rotenone Toxicity in an In Vitro Model of Parkinson’s Disease
por: Ostendorf, Friederike, et al.
Publicado: (2020)

Three cases of non-carryover fingolimod-PML: Is the risk in Japan increased?
por: Nakahara, Jin, et al.
Publicado: (2019)

Preserved T-cell response in anti-CD20-treated multiple sclerosis patients following SARS-CoV-2 vaccination
por: Faissner, Simon, et al.
Publicado: (2022)

Short-chain fatty acids in the context of Parkinson’s disease
por: Metzdorf, Judith, et al.
Publicado: (2021)

Emerging Immunotherapies for Parkinson Disease
por: Zella, Samis M. A., et al.
Publicado: (2018)

Brainstem Encephalitis With Low-Titer Acetylcholine Receptor Antibodies Mimicking Myasthenia Gravis
por: Ayzenberg, Ilya, et al.
Publicado: (2019)

Multiple sclerosis is not associated with an increased risk for severe COVID-19: a nationwide retrospective cross-sectional study from Germany
por: Richter, Daniel, et al.
Publicado: (2021)

The impact of the COVID-19 pandemic on hospitalizations and plasmapheresis therapy in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide analysis from Germany
por: Richter, Daniel, et al.
Publicado: (2021)

Inpatient care of neuromyelitis optica spectrum disorder in Germany: Nationwide analysis from 2010 to 2021
por: Richter, Daniel, et al.
Publicado: (2023)

Aquaporin-4 antibodies in patients treated with natalizumab for suspected MS
por: Gahlen, Anna, et al.
Publicado: (2017)

Progressive Retinal and Optic Nerve Damage in a Mouse Model of Spontaneous Opticospinal Encephalomyelitis
por: Petrikowski, Laura, et al.
Publicado: (2022)

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
por: Zella, Maria Angela Samis, et al.
Publicado: (2019)

A Propagated Skeleton Approach to High Throughput Screening of Neurite Outgrowth for In Vitro Parkinson’s Disease Modelling
por: Schikora, Justus, et al.
Publicado: (2021)

Capsaicin-enriched diet ameliorates autoimmune neuritis in rats
por: Motte, Jeremias, et al.
Publicado: (2018)

SARS-CoV-2, COVID-19 and Neurodegeneration
por: Tönges, Lars, et al.
Publicado: (2022)

Fingolimod and Teriflunomide Attenuate Neurodegeneration in Mouse Models of Neuronal Ceroid Lipofuscinosis
por: Groh, Janos, et al.
Publicado: (2017)

A Comprehensive Monitoring Study on Electrocardiographic Assessments and Cardiac Events After Fingolimod First Dose—Possible Predictors of Cardiac Outcomes
por: Limmroth, Volker, et al.
Publicado: (2020)

Intrathecal triamcinolone acetonide exerts anti-inflammatory effects on Lewis rat experimental autoimmune neuritis and direct anti-oxidative effects on Schwann cells
por: Pitarokoili, Kalliopi, et al.
Publicado: (2019)

Prophylactic Glatiramer Acetate Treatment Positively Attenuates Spontaneous Opticospinal Encephalomyelitis
por: Koc, Ümmügülsüm, et al.
Publicado: (2023)

Serum neurofilament light chain as outcome marker for intensive care unit patients
por: Fisse, Anna Lena, et al.
Publicado: (2020)

Clozapine Regulates Microglia and Is Effective in Chronic Experimental Autoimmune Encephalomyelitis
por: Ceylan, Ulaş, et al.
Publicado: (2021)

New Approaches to Critical Illness Polyneuromyopathy: High-Resolution Neuromuscular Ultrasound Characteristics and Cytokine Profiling
por: Fisse, Anna Lena, et al.
Publicado: (2020)

Multiple Sclerosis Disease Activity and Disability Following Cessation of Fingolimod for Pregnancy
por: Hellwig, Kerstin, et al.
Publicado: (2023)

Early immunotherapy is highly effective in IgG1/IgG4 positive IgLON5 disease
por: Grüter, Thomas, et al.
Publicado: (2020)

Determination of Seminal Concentration of Fingolimod and Fingolimod‐Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod
por: David, Olivier J., et al.
Publicado: (2017)

General principles and escalation options of immunotherapy in autoantibody-associated disorders of the CNS
por: Ayzenberg, Ilya, et al.
Publicado: (2019)

Fingolimod Rescues Demyelination in a Mouse Model of Krabbe's Disease
por: Béchet, Sibylle, et al.
Publicado: (2020)

Dimethyl fumarate vs fingolimod following different pretreatments: A retrospective study
por: Diem, Lara, et al.
Publicado: (2020)

Parkinson’s disease multimodal complex treatment improves gait performance: an exploratory wearable digital device-supported study
por: Scherbaum, Raphael, et al.
Publicado: (2022)

Amphiphysin-positive paraneoplastic myelitis and stiff-person syndrome
por: Faissner, Simon, et al.
Publicado: (2016)

Brainstem Raphe Alterations in TCS: A Biomarker for Depression and Apathy in Parkinson's Disease Patients
por: Richter, Daniel, et al.
Publicado: (2018)

Parkinson’s Disease Multimodal Complex Treatment (PD-MCT): Analysis of Therapeutic Effects and Predictors for Improvement
por: Hartelt, Elke, et al.
Publicado: (2020)

Analysis of nationwide multimodal complex treatment and drug pump therapy in Parkinson's disease in times of COVID-19 pandemic in Germany
por: Richter, Daniel, et al.
Publicado: (2021)

Propionate exerts neuroprotective and neuroregenerative effects in the peripheral nervous system
por: Grüter, Thomas, et al.
Publicado: (2023)

Fingolimod Rescues Memory and Improves Pathological Hallmarks in the 3xTg-AD Model of Alzheimer’s Disease
por: Fagan, Steven G., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lpltimchmo8oo5ipsd4n7v8io9